Scholarlink

<p>Identifying common host factors essential for the replication cycles of human coronaviruses (HCoV) could help uncover potential therapeutic targets. Mitogen-activated protein kinases (MAPKs) regulate critical cellular signaling pathways. Among them, c-Jun N-terminal kinases (JNK) are activated in response to diverse environmental stresses, including viral infections. However, the relevance of the JNK pathway for host responses and replication of HCoV infections has remained elusive. Using live-cell microscopy, quantitative immunofluorescence and immunoblotting, we found that JNK is specifically activated in cells infected with HCoV-229E and plays a crucial role in mediating the phosphorylation of the viral nucleocapsid (N) protein, an essential step required during the viral replication cycle. Consequently, pharmacological inhibition of JNK kinase activity impeded HCoV-229E as well as SARS-CoV-2 infection. Given the conservation of phosphorylation sites within the nucleocapsid protein across coronaviruses, inhibitors targeting these N protein kinases, such as JNK, may hold therapeutic promise as broad-spectrum CoV antivirals.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

JNK kinase regulates phosphorylation of HCoV-229E nucleocapsid protein

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月18日

查看全文
  • Yannick Brüggemann,
  • Toni Luise Meister,
  • Natalie Heinen,
  • Emely Richter,
  • Saskia Westhoven,
  • Michael Poppe,
  • Mohammed Samer Shaban,
  • Leyla Sirkinti,
  • Maximilian Nocke,
  • Daniel Todt,
  • Stephanie Pfaender,
  • Michael Kracht,
  • Eike Steinmann

摘要

Identifying common host factors essential for the replication cycles of human coronaviruses (HCoV) could help uncover potential therapeutic targets. Mitogen-activated protein kinases (MAPKs) regulate critical cellular signaling pathways. Among them, c-Jun N-terminal kinases (JNK) are activated in response to diverse environmental stresses, including viral infections. However, the relevance of the JNK pathway for host responses and replication of HCoV infections has remained elusive. Using live-cell microscopy, quantitative immunofluorescence and immunoblotting, we found that JNK is specifically activated in cells infected with HCoV-229E and plays a crucial role in mediating the phosphorylation of the viral nucleocapsid (N) protein, an essential step required during the viral replication cycle. Consequently, pharmacological inhibition of JNK kinase activity impeded HCoV-229E as well as SARS-CoV-2 infection. Given the conservation of phosphorylation sites within the nucleocapsid protein across coronaviruses, inhibitors targeting these N protein kinases, such as JNK, may hold therapeutic promise as broad-spectrum CoV antivirals.